Magnesium (Mg 21 ) is the fourth most abundant cation in the body. Thus, magnesium homeostasis needs to be tightly regulated, and this is facilitated by intestinal absorption and renal excretion. Magnesium absorption is dependent on two concomitant pathways found in both in the intestine and the kidneys: passive paracellular transport via claudins facilitates bulk magnesium absorption, whereas active transcellular pathways mediate the fine-tuning of magnesium absorption. The identification of genes responsible for diseases associated with hypomagnesaemia resulted in the discovery of several magnesiotropic proteins. Claudins 16 and 19 form the tight junction pore necessary for mass magnesium transport. However, most of the causes of genetic hypomagnesaemia can be tracked down to transcellular magnesium transport in the distal convoluted tubule. Within the distal convoluted tubule, magnesium reabsorption is a tightly regulated process that determines the final urine magnesium concentration. Therefore, insufficient magnesium transport in the distal convoluted tubule owing to mutated magnesiotropic proteins inevitably leads to magnesium loss, which cannot be compensated for in downstream tubule segments. Better understanding of the molecular mechanism regulating magnesium reabsorption will give new opportunities for better therapies, perhaps including therapies for patients with chronic renal failure.
Introduction
As magnesium (Mg 21 ) is a cofactor of many enzymes, it is involved in all major cellular processes such as energy metabolism, DNA transcription and protein synthesis. Physiologically, Mg 21 plays an essential role in bone formation, neuromuscular stability and muscle contraction. Therefore, the tight regulation of plasma Mg 21 levels is of vital importance. Hypomagnesaemia occurs because of decreased gastrointestinal absorption or increased renal Mg 21 excretion and is associated with a wide spectrum of diseases, including Type 2 diabetes, hypertension, osteoporosis, tetany, seizures and depression [1] [2] [3] [4] . This issue has been discussed in greater detail in the review by Jahnen-Dechent and Ketteler [5] and Geiger and Wanner [6] in this supplement. Certain drug therapies (e.g. diuretics, aminoglycosides, cetuximab therapy and immunosuppressive agents) can result in acquired renal Mg 21 wasting and associated low serum Mg 21 levels [7] . Hypomagnesaemia can be treated with oral Mg 21 supplements, though at high doses these might cause diarrhoea. Oral Mg 21 supplements are also often given with potassium (K 1 ) supplements because Mg 21 deficiency is frequently associated with hypokalaemia [8] . In severely hypomagnesaemic patients, intravenous supplementation can be essential to restore the patient's Mg 21 levels without discomforting the patient. During the last decade, human hereditary disorders have given great insight into the molecular pathways involved in the regulation of Mg 21 homeostasis (Table 1) . In this review, we will focus on the regulation of magnesium homeostasis and we will describe the genetic causes of hypomagnesaemia and the underlying molecular mechanisms.
Regulation of magnesium homeostasis
Many studies have shown intestinal Mg 21 absorption is balanced against renal Mg 21 excretion [9] [10] [11] . In times of a temporary Mg 21 deficit, the body depends on the availability of Mg 21 in bone to maintain constant serum levels [12] . Therefore, Mg 21 homeostasis depends on three organs: the intestine, facilitating Mg 21 uptake; bone, the Mg 21 storage system of the body and the kidneys, which are responsible for Mg 21 excretion.
Intestinal magnesium uptake
In healthy people, Mg 21 blood plasma concentrations range between 0.65 and 1.05 mmol/L. In order to maintain these levels, a daily Mg 21 intake of 320 mg for men and 420 mg for women is recommended by the US Food and Nutrition Board. Approximately 30-50% of dietary Mg 21 is absorbed by the intestine (Figure 1 ). However, when Mg 21 intake is low, the absorption percentage can rise tõ 80% [13] . Mg 21 absorption takes place mainly in the distal small intestine and in the colon [14] . Thus, shortening of the rat ileum, for example, results in a substantial decrease of Mg 21 absorption [15] .
Absorption pathways. Two Mg 21 -absorbing pathways have been identified in the mammalian intestine ( Figure 2 ). Paracellular transport involves the absorption of Mg 21 through the small spaces between the epithelial cells and is a passive mechanism. Secondly, the transcellular pathway involves the active transport of Mg 21 to the blood through the interior of the epithelial cell. This second type of Mg 21 transport is subject to tight regulation since the ions have to pass through two cell membranes. concentration, which ranges between 1.0 and 5.0 mmol/L, and the lumen-positive transepithelial voltage of~15 mV [2] . Paracellular Mg 21 absorption relies on tight junction permeability, which is still poorly understood. The ileum and distal parts of the jejunum are known to be the most permeable for ions because of the relatively low expression of 'tightening' claudins 1, 3, 4, 5 and 8 [16] . As such, paracellular Mg 21 transport seems mainly restricted to these areas that lack the 'tightening' claudins. Claudins 16 and 19, known to be involved in Mg 21 permeability [17] , are not expressed in the intestine [16] . The exact mechanism facilitating paracellular Mg 21 absorption, therefore, remains unknown. Transient receptor potential channel melastatin member 6 (TRPM6) and TRPM7 Mg 21 channels mediate transcellular absorption. Whereas TRPM7 is ubiquitously expressed; intestinal TRPM6 expression is mainly detected in the distal small intestine and colon in murine tissue at least, though this result needs to be confirmed in humans [18] . Both TRPM6 and TRPM7 expression is restricted to the luminal membrane of the enterocytes (Figure 2 [13] . This effect can be attributed, at least partly, to changes in TRPM6 expression in the colon [18] . It also, probably, depends on alterations in paracellular Mg 21 transport rates owing to changes in the electrochemical gradient. 
Magnesium storage
While Mg 21 can be stored in muscle fibres, where it plays an important role in the regulation of muscle contraction by antagonizing the action of Ca 21 [26] , bone tissue is the largest Mg 21 store in the human body (Figure 1 ), where it also contributes to the density and strength of the skeleton. Depletion of Mg 21 is, therefore, a risk factor for osteoporosis [27] . A model of Mg 21 -induced bone loss has been proposed in which low blood plasma Mg 21 concentrations lead to activation of bone resorption by osteoclasts and decreased osteoblast bone formation [27] . Moreover, bone surface Mg 21 concentrations (of~30%) are closely related to serum Mg 21 concentrations, indicating a continuous exchange of Mg 21 between bone and blood [12] .
Renal magnesium elimination
Approximately 2400 mg of Mg 21 is filtered daily by the glomeruli. Along the nephron, 90-95% of Mg 21 is retrieved; A daily net intake of~100 mg in the intestine results in a balanced 100 mg excretion in the kidney. In times of Mg 21 shortage, other tissues such as bone and muscle provide Mg 21 to restore blood Mg 21 levels. See also ''Magnesium basics'' in this supplement [5] . The conversion factor from milligrams to millimole is 0.04113. the remaining 100 mg leaves the body via the urine (Figure 1 ). The specific roles of the various parts of the nephron are considered in the following sections. [28] .
Thick ascending limb. The majority of filtered Mg 21 is reabsorbed in the loop of Henle, mostly in the thick ascending limb which accounts for up to 70% of total Mg 21 reabsorption ( Figure 3 ). In fact, Mg 21 is the only bulktransported ion in the thick ascending limb of the loop of Henle. Mg 21 reabsorption in the proximal tubule and thick ascending limb is, in fact, the opposite to the reabsorption of Na 1 and K 1 , which occurs mainly in the proximal tubule rather than in the thick ascending limb.
The transepithelial voltage gradient is the driving force behind the passive paracellular transport of Mg 21 in the thick ascending limb (voltages in the tubular lumen are positive relative to blood). Furthermore, it has been shown recently that claudins 16 and 19 form a cation-selective tight junction, facilitating the paracellular transport of Mg 21 in the thick ascending limb [17, 29] . The role of these claudins in bulk Mg 21 transport can still be questioned, however, since their Mg 21 transport capacity is fairly low when they are reconstituted in proximal tubule cells [30] . Nevertheless, the current theory proposes that NaCl enters thick ascending loop cells via the apical furosemide-sensitive Na 21 extrusion mechanism remains to be identified, it may be dependent on the inward Na 1 gradient that is mediated by the Na 1 /K 1 -ATPase ( Figure 5 ). Notably, thiazide diuretics mimic the effects of Gitelman's syndrome by enhancing Na 1 excretion via inhibition of the Na 1 -Cl À cotransporter (NCC) ( Figure 5 ). In addition, these drugs are known to affect the Mg 21 balance, inducing hypomagnesaemia, which may be explained by the down-regulation of TRPM6 expression in response to chronic thiazide treatment [35] . Hypomagnesaemia is frequently linked with hypokalaemia owing to disturbances in renal K 1 secretion in the connecting tubule and collecting duct (Figure 3 ). Low intracellular Mg 21 levels release the Mg 21 -dependent inhibition of ROMK channels, resulting in increased renal K 1 secretion, often leading to hypokalaemia [8] .
Regulatory factors. Epidermal growth factor (EGF) regulates TRPM6 activity and plasma membrane availability. Interestingly, basolaterally expressed pro-EGF is almost exclusively found in the distal convoluted tubule. Pro-EGF [28] . CNT, connecting tubule; CD, collecting duct. is cleaved to yield EGF, activating the EGF receptor (EGFR), which in turn triggers an intracellular cascade that regulates TRPM6 activity [36] .
Oestrogen is known to stimulate TRPM6 expression [18] . Thus, oestrogen substitution therapy is used to normalize hypermagnesuria, which occurs frequently in postmenopausal women [37] . Interestingly, TRPM6 expression appears to be regulated by plasma Mg 21 levels and oestrogens, but not by 1,25(OH) 2 D 3 or parathyroid hormone (PTH) action [18] .
Magnesium transporters and genetic disease
In the last decade, gene-linkage studies in families with hereditary forms of hypomagnesaemia have helped identify several proteins involved in renal Mg 21 reabsorption (Table 1) . Causative mutations for several genetic disorders have been described and have provided insight in the molecular regulation of Mg 21 transport. In this review, we will present an overview of the implicated diseases and proteins. Bartter's syndrome-associated genes. Bartter's syndrome is a group of autosomal-recessive disorders characterized by reduced salt absorption in the thick ascending limb, the target segment of the furosemide diurectics. This salt wasting often coincides with hypokalaemic metabolic alkalosis, elevated renin and aldosterone levels and low blood pressure [7] . Mutations in five different genes have been shown to induce the Bartter phenotype [41, 42] 
Impaired Mg 21 reabsorption in the distal convoluted tubule
Transient receptor potential channel melastatin member 6 (TRPM6). Two groups identified TRPM6, simultaneously and independently, as the causative gene in the rare genetic disorder of hypomagnesaemia with secondary hypocalcaemia (HSH) [44, 45] . HSH-affected individuals have abnormally low serum Mg 21 levels (<0.40 mmol/L) that indirectly lead to hypocalcaemia, probably because of concomitant parathyroid failure. Patients suffer from neurological symptoms such as seizures and muscle spasms, and eventually, the disorder may be fatal or cause neurological damage if not treated with high-dose Mg 21 . TRPM6 belongs to the family of transient receptor potential channels that facilitate electrolyte transport. TRPM6 consists of six membrane-spanning domains with a pore-forming region and intracellular C-and N-terminal. In the nephron, TRPM6 expression is limited to the apical membrane of distal convoluted tubule cells, whereas intestinal TRPM6 expression is highest in the colon and caecum [18] . Patch-clamp analysis showed that TRPM6 is a Mg 21 -and Ca 21 -permeable cation channel, which preferentially transports Mg 21 [34] . TRPM6 proteins form homotetrameric functional complexes as well as heterotetrameric complexes with TRPM7, the closest homologue of TRPM6 [46] . Recently, there has been controversy about the necessity of TRPM7 in TRPM6 functioning, as TRPM7-dependent as well as TRPM7-independent TRPM6 activity has been reported [47, 48] . The TRPM6 protein contains a C-terminal a-kinase domain that seems important in regulatory functions. Interactions between the a-kinase domain and regulatory factors such as receptor for activated C-kinase 1 (RACK1) and repressor of oestrogen receptor activity (REA) have been shown to modulate TRPM6 activity [49] . TRPM6 knockout mice are lethal, but TRPM6 heterozygous mice survive and have significantly lower plasma Mg 21 levels owing to reduced intestinal and renal expression of TRPM6 [50] . Several TRPM6 lossof-function mutations have been demonstrated to decrease TRPM6 activity [51] . TRPM6 mutations often affect tetramerization or trafficking to the plasma membrane, but recently, a missense mutation in the pore-forming domain has been reported which leads to a functionally inactive channel [52] .
Epidermal growth factor. The first reports of the involvement of EGF in the regulation of Mg 21 reabsorption dates from 2005, when symptomatic hypomagnesaemia was observed in a patient with colorectal cancer who was treated with cetuximab, a monoclonal antibody directed against the EGFR [53] . Two years later, EGF was linked to isolated renal hypomagnesaemia (IRH), a rare disorder of low serum Mg 21 concentrations because of renal Mg 21 wasting. Whole-genome linkage analysis and subsequent candidate gene analysis in a family with IRH (Mg 21 serum levels~0.5 mmol/L) resulted in the identification of mutations in the EGF gene [54] . In addition to hypomagnesaemia, the IRH phenotype consists of moderate mental retardation and epileptic seizures. The EGF gene encodes a membrane-bound precursor molecule, pro-EGF, which is proteolytically cleaved to release the active form of the EGF hormone. Pro-EGF is expressed both on luminal and basolateral membranes of distal convoluted tubule cells, but EGFR itself is found only on the basolateral membrane.
Hypomagnesaemia was also found as a side effect in a prospective study in colorectal cancer patients given cetuximab therapy, and the authors suggested the involvement of EGF in TRPM6 regulation [55] . Follow-up studies revealed that EGF increases activity and membrane trafficking of TRPM6, and thus, it is the first hormone directly regulating renal Mg 21 reabsorption [56] . The expression of EGF is restricted to the TRPM6-expressing distal convoluted tubule cells. In the kidney, EGF is, therefore, a dedicated hormone regulating the Mg 21 reabsorption in a para-or autocrine fashion. Moreover, Ikari et al. [36, 57] reported that EGF regulates TRPM6 transcription via a MEK/ERK/AP-1 pathway, and activation of TRPM6 expression by EGF was confirmed recently in vivo in a study with EGFR-inhibitor erlotinib [58] . The mutation that led to the discovery of EGF as magnesiotropic hormone causes impaired basolateral expression of pro-EGF as it disrupts the basolateral-sorting motif. As a consequence, TRPM6 activity and membrane expression are reduced, and thus less Mg 21 is reabsorbed in the distal convoluted tubule.
Thiazide-sensitive Na 1 -Cl À cotransporter (NCC). Gitelman's syndrome is an inherited disorder of impaired salt transport in the distal convoluted tubule and is associated with hypomagnesaemia, hypocalciuria and secondary aldosteronism [7] . Patients generally suffer from tetany, fatigue, chondrocalcinosis and muscle weakness. Gitelman's syndrome is caused by mutations in the thiazide-sensitive Na 1 -Cl À cotransporter (NCC) gene, resulting in loss of function of the protein. NCC is responsible for apical Na 1 and Cl À entry into distal convoluted tubule cells and is sensitive to thiazide blocking [59, 60] . This characteristic of NCC was used in a study investigating the effect of NCC blocking on Ca 21 and Mg 21 reabsorption. The authors showed that thiazide-treated mice have abnormally low expression levels of TRPM6 in the distal convoluted tubule, causing hypomagnesaemia [35] . However, the interesting cross-talk mechanism between NCC activity and TRPM6 expression remains to be resolved.
Indirect reduction of Mg
21 transport in the distal convoluted tubule: transmembrane voltage Kv1.1 K 1 channel (KCNA1). Single nucleotide polymorphism-based linkage analysis in a family with autosomaldominant hypomagnesaemia resulted in the identification of mutations in the KCNA1 gene, encoding the Kv1.1 K 1 channel. Affected individuals have severe hypomagnesaemia (<0.40 mmol/L) and suffer from muscle cramps, tetanic episodes, tremor and muscle weakness. Kv1.1 is a voltagegated K 1 channel and consists of six transmembrane domains, one of which (S4) acts as the voltage sensor and two (S5/S6) that form the pore region. Immunohistochemistry showed that kidney Kv1.1 localization is restricted to the luminal membrane of distal convoluted tubule cells ( Figure 5 ). In these cells, Kv1.1 is thought to be involved in maintenance of the optimal membrane voltage, which is the driving force behind Mg 21 reabsorption via TRPM6 [61] . Interestingly, the Kv1.1 K 1 current is blocked by intracellular Mg 21 , thereby preventing intracellular Mg 21 overload [62] . The N255H mutation, leading to the discovery of the involvement of the KCNA1 gene in Mg 21 transport, locates in the third membrane-spanning domain and results in a non-functional channel. The asparagine at Position 255 is required for normal channel gating and voltage dependence [63] . It would be interesting to further characterize Mg
Patients with dominant renal hypomagnesaemia associated with hypocalciuria suffer from renal Mg 21 wasting and convulsions. Linkage studies followed by candidate screening led to the discovery of the FXYD domain containing the ion transport regulator 2 (FXYD2) gene coding for the c-subunit of the Na 1 /K 1 -ATPase as the causative gene [65] . The basolateral Na 1 /K 1 -ATPase allows the active transport of Na 1 and K 1 transport in the opposite direction ( Figure 5 ). The c-subunit regulates the kinetics of Na 1 /K 1 -ATPase-mediated exchange of Na 1 and K 1 . Immunohistochemistry confirmed colocalization of the ca-and cb-subunits at the basolateral membrane of the distal convoluted tubule [66] . Moreover, Na 1 /K 1 -ATPase activity is highest in this part of the nephron [67] . The currently leading hypothesis states that reduced Na 1 transport lowers the membrane potential across the luminal membrane that acts as the inward electrical driving force for Mg 21 . As a consequence, Mg 21 reabsorption is reduced. The glycine to arginine mutation at amino acid Position 41 (G41R) found in a Dutch family causes misrouting of the FXYD2 complex to the basolateral membrane [65] . G41R-mutated subunits oligomerize with wild-type FXYD2, thereby retaining the complex in the cell [68] . A recent study of the G41R mutation proposed a role for FXYD2 as an inward rectifying channel. These findings resulted in the suggestion that FXYD2 mediates basolateral Mg 21 extrusion [69] . Future studies, however, need to address the exact role of the c-subunit of the Na 1 /K 1 -ATPase in the distal convoluted tubule.
Hepatocyte nuclear factor 1 homeobox B (HNF1B). Mutations in the HNF1B transcription factor are associated with many human disorders such as neonatal diabetes and renal malformation. Recently, HNF1B mutations were linked to hypomagnesaemia in a 13-year-old Pakistani boy and a cohort of patients with HFN1B mutations and renal malformations. Forty-four per cent of the HNF1B mutation carriers have hypomagnesaemia, hypermagnesuria and hypocalciuria [70] . Luciferase reporter assays demonstrated that HNF1B stimulates transcriptional expression of the FXYD2a gene [66] . Mutations in HFN1B prevented transcriptional activation of the ca-subunit of the Na 1 /K 1 -ATPase, underlining the importance of the Na 1 /K 1 -ATPase in renal Mg 21 reabsorption.
Kir4.1 K 1 channel (KCNJ10). Quantitative trait loci mapping studies of seizure-sensitive mice led to the nomination of KCNJ10 as the responsible gene [71] . Recently, two groups confirmed that hypomagnesaemia (~0.6 mmol/L) associated with seizures, sensorineural deafness, ataxia, mental retardation and electrolyte imbalance (SeSAME syndrome, also referred to as EAST) is provoked by mutations in the KCJN10 gene, which encodes the Kir4.1 K 1 channel [72, 73] . Kir4.1 is expressed in glial cells, epithelium of the inner ear and the basolateral side of kidney distal convoluted tubule cells, where it is involved in K 1 recycling necessary for optimal Na 1 /K 1 -ATPase activity [74] ( Figure 5 ). By this mechanism, it is indirectly involved in the regulation of the intracellular voltage that is required for Mg 21 transport, explaining the hypomagnesaemia observed in patients with Kir4.1 mutations.
Kir4.1 and the CaSR have recently been shown to physically interact in human embryonic kidney cells and in kidney homogenates, and the CaSR appears to regulate Kir4.1 activity by decreasing Kir4.1 membrane availability via a Gaand caveolin-dependent pathway [75] . A Kir4.1 knockout mouse model is available, but no data on kidney Mg 21 transport from this model has been published. The Kir4.1 À/À mice have severe neurological problems and die prematurely (in the first few weeks after birth) [76, 77] . Several Kir4.1 mutations identified in SeSAME syndrome patients have been studied, and although all mutations modified the channel function, the mechanisms underlying these disturbances are different. Some mutations resulted in a shift in pH sensitivity causing changes in pore gating, while others impaired correct protein folding and decreased surface expression [78] . 21 channel, and it is regulated by a variety of factors (of which EGF is the best studied). Pro-EGF is cleaved from the distal convoluted tubule cell, releasing EGF, where it can activate the EGFR at the basolateral membrane. TRPM6 can form homotetrameric complexes and heterotetrameric complexes with TRPM7; however, the necessity of TRPM7 for TRPM6 functioning is controversial. TRPM6 activity is dependent on the transmembrane voltage that is kept intact by the luminal K 1 channel Kv1.1, but the exact role of Kv1.1 has to be further examined.
Conclusions and future perspectives
The basolateral Mg 21 extrusion mechanism is less well understood but is known to be linked to the basolateral Na 1 /K 1 -ATPase. Na 1 /K 1 -ATPase activity is regulated by the HNF1B transcriptional factor, which stimulates the expression of FXYD2. Also, the Kir4. Genetic research in families with hypomagnesaemia has expanded our understanding of renal Mg 21 reabsorption. Understanding these processes can lead to new therapies for chronic hypomagnesaemia, and new state-of-the-art DNA screening techniques can help identify the missing magnesiotropic genes. Recent developments in renal Mg 21 research are excellent examples of bedside-to-bench research cooperation between clinicians and fundamental researchers and continuation of these collaborations may also allow new insights into the sequence of events that occurs when chronic renal failure develops.
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